CN104432046A - 男性日用保健品 - Google Patents
男性日用保健品 Download PDFInfo
- Publication number
- CN104432046A CN104432046A CN201410745593.4A CN201410745593A CN104432046A CN 104432046 A CN104432046 A CN 104432046A CN 201410745593 A CN201410745593 A CN 201410745593A CN 104432046 A CN104432046 A CN 104432046A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- rhizoma polygonati
- health product
- male sex
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000036541 health Effects 0.000 title abstract description 8
- 239000000284 extract Substances 0.000 claims abstract description 124
- 150000004676 glycans Chemical class 0.000 claims abstract description 11
- 229920001282 polysaccharide Polymers 0.000 claims abstract description 11
- 239000005017 polysaccharide Substances 0.000 claims abstract description 11
- 241000005787 Cistanche Species 0.000 claims abstract description 10
- 241000893536 Epimedium Species 0.000 claims abstract description 10
- 244000241838 Lycium barbarum Species 0.000 claims abstract description 10
- 235000015459 Lycium barbarum Nutrition 0.000 claims abstract description 10
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 10
- 229940107628 american ginseng root Drugs 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 10
- 235000018905 epimedium Nutrition 0.000 claims abstract description 10
- 210000000582 semen Anatomy 0.000 claims abstract description 10
- 235000001287 Guettarda speciosa Nutrition 0.000 claims description 9
- 241000756943 Codonopsis Species 0.000 claims description 8
- 239000002775 capsule Substances 0.000 claims description 3
- 244000061520 Angelica archangelica Species 0.000 claims 2
- 241001061264 Astragalus Species 0.000 abstract description 4
- 235000006533 astragalus Nutrition 0.000 abstract description 4
- 210000004233 talus Anatomy 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract 2
- 241000382455 Angelica sinensis Species 0.000 abstract 1
- 241000007126 Codonopsis pilosula Species 0.000 abstract 1
- 241000500125 Cynomorium coccineum Species 0.000 abstract 1
- 241000222336 Ganoderma Species 0.000 abstract 1
- 241000305492 Gastrodia Species 0.000 abstract 1
- 241000756042 Polygonatum Species 0.000 abstract 1
- 235000008737 Polygonatum biflorum Nutrition 0.000 abstract 1
- 240000001341 Reynoutria japonica Species 0.000 abstract 1
- 235000018167 Reynoutria japonica Nutrition 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 15
- 230000000694 effects Effects 0.000 description 15
- 210000004369 blood Anatomy 0.000 description 14
- 239000000047 product Substances 0.000 description 11
- 241000125175 Angelica Species 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 230000007812 deficiency Effects 0.000 description 6
- 201000001881 impotence Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 206010010774 Constipation Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- 230000003712 anti-aging effect Effects 0.000 description 4
- 230000002929 anti-fatigue Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 201000004384 Alopecia Diseases 0.000 description 3
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 231100000360 alopecia Toxicity 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 231100000862 numbness Toxicity 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000007958 sleep Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 206010049865 Achromotrichia acquired Diseases 0.000 description 2
- 206010062767 Hypophysitis Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 208000002193 Pain Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 2
- 230000003656 anti-hair-loss Effects 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000003727 cerebral blood flow Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000001934 delay Effects 0.000 description 2
- 206010012601 diabetes mellitus Diseases 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 230000035558 fertility Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 230000036299 sexual function Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- IAJILQKETJEXLJ-KLVWXMOXSA-N (2s,3r,4r,5r)-2,3,4,5-tetrahydroxy-6-oxohexanoic acid Chemical compound O=C[C@H](O)[C@H](O)[C@@H](O)[C@H](O)C(O)=O IAJILQKETJEXLJ-KLVWXMOXSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241000304886 Bacilli Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- QCDFBFJGMNKBDO-UHFFFAOYSA-N Clioquinol Chemical compound C1=CN=C2C(O)=C(I)C=C(Cl)C2=C1 QCDFBFJGMNKBDO-UHFFFAOYSA-N 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 241000804384 Cynomorium songaricum Species 0.000 description 1
- AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 241000305491 Gastrodia elata Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 241000282376 Panthera tigris Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044684 Trismus Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000009098 adjuvant therapy Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000002155 anti-virotic effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000035617 depilation Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 206010015037 epilepsy Diseases 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000000091 immunopotentiator Effects 0.000 description 1
- 208000033065 inborn errors of immunity Diseases 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000000938 luteal effect Effects 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000036407 pain Effects 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000003635 pituitary gland Anatomy 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 208000028529 primary immunodeficiency disease Diseases 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 230000003860 sleep quality Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 230000002557 soporific effect Effects 0.000 description 1
- 235000015096 spirit Nutrition 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Abstract
本发明提供了一种男性日用保健品，由重量份数的以下组份组成：西洋参根部提取物0.3-0.8份，当归提取物0.5-1.5份、党参提取物0.5-1.5份，枸杞提取物1-2份、何首乌提取物1-2份，熟地提取物0.5-1.5份，菟丝子提取物0.3-0.8份，黄氏多糖0.3-0.8份，肉苁蓉提取物0.3-0.8份，黄精提取物0.5-1.5份，玉竹提取物1-2份，灵芝提取物0.5-1.5份，天麻提取物0.5-1.5份，锁阳提取物0.5-1.5份，淫羊藿提取物0.3-0.8份。本发明均采用提取物而非直接服用，有效营养成分含量高，更有利于吸收。适合现代男性使用。
Description
技术领域
本发明涉及一种男性日用保健品。
背景技术
随着人们对疾病治疗观念转变，治疗的重点已经由直接杀伤外源性病原体转向调整生物机体自身功能，从而免疫增强剂在医学的应用引起广泛关注，期望健康、预防疾病，尤其是传染性疾病的突然袭击，是人们当前普遍也是十分正常的愿望。
现代职业男性和中老年男性，因责任重大，工作繁重，饮酒、吸烟、熬夜、营养失衡、久坐、缺乏运动，处于亚健康状态，过早出现“三高”，骨质疏松，脱发，性功能下降等。
现在缺少一种针对以上问题的综合性考虑的纯中药制剂的保健品，市场上已有的保健品都是针对某一方面的作用，往往要服用很多种保健品，但是最后不知道哪一种发挥了作用，并且出现顾此失彼的现象。
发明内容
本发明的目的是针对现有技术的不足，提供一种有效营养成分高、增强免疫力、抗疲劳、抗衰老、提神、壮阳的男性日用保健品。
本发明的目的是这样实现的：一种男性日用保健品，其特征在于：由重量份数的以下组份组成：西洋参根部提取物0.3-0.8份，当归提取物0.5-1.5份、党参提取物0.5-1.5份，枸杞提取物1-2份、何首乌提取物1-2份，熟地提取物0.5-1.5份，菟丝子提取物0.3-0.8份，黄氏多糖0.3-0.8份，肉苁蓉提取物0.3-0.8份，黄精提取物0.5-1.5份，玉竹提取物1-2份，灵芝提取物0.5-1.5份，天麻提取物0.5-1.5份，锁阳提取物0.5-1.5份，淫羊藿提取物0.3-0.8份。
作为上述方案的优选：由重量份数的以下组份组成：西洋参根部提取物0.4-0.6份，当归提取物0.8-1.2份、党参提取物0.8-1.2份，枸杞提取物1.2-1.8份、何首乌提取物1.2-1.8份，熟地提取物0.8-1.2份，菟丝子提取物0.4-0.6份，黄氏多糖0.4-0.6份，肉苁蓉提取物0.4-0.6份，黄精提取物0.8-1.2份，玉竹提取物1.2-1.8份，灵芝提取物0.8-1.2份，天麻提取物0.8-1.2份，锁阳提取物0.8-1.2份，淫羊藿提取物0.4-0.6份。
上述方案中：西洋参根部提取物有补气养阴、清热生津之功效。具有镇静、增强记忆力、促进神经生长的作用。对于高血压和心肌营养不良、冠心病、心绞痛等亦有一定疗效。
当归提取物补血；活血；调经止痛；润燥滑肠，主治血虚诸证；月经不调；经闭；痛经；症瘕结聚；崩漏；虚寒腹痛；痿痹；肌肤麻木；肠燥便难；赤痢后重；痈疽疮疡；跌扑损伤。
枸杞提取物：养肝，滋肾，润肺。枸杞叶：补虚益精，清热明目。
何首乌提取物补益精血；解毒，截疟，润肠通便补益药；祛风药，主治血虚头昏目眩；心悸；失眠；肝肾阴虚之腰膝酸软；须发早白；耳鸣；遗精；肠燥便秘；久疟体虚；风疹瘙痒；疮痈；瘰疬；痔疮。
熟地提取物补血滋润；益精填髓。主治：血虎萎黄；眩晕心悸；月经不调；崩不止；肝肾阴亏；潮热盗汗；遗精阳痿；不育不孕；腰膝酸软；耳鸣耳聋；头目昏花；须发早白；消渴；便秘；肾虚喘促。
菟丝子提取物可以增加下丘脑-垂体-卵巢促黄体功能，这种作用并不是由于它们直接刺激垂体促黄体激素的分泌，而是由于提高了垂体对LRH及卵巢对LH的反应性。
黄氏多糖是豆科植物蒙古黄芪或膜荚黄芪的干燥根经提取、浓缩、纯化而成的水溶性杂多糖。淡黄色，粉末细腻，均匀无杂质，具引湿性。黄芪多糖由己糖醛酸、葡萄糖、果糖、鼠李糖、阿拉伯糖、半乳糖醛酸和葡萄糖醛酸等组成，可作为免疫促进剂或调节剂，同时具有抗病毒、抗肿瘤、抗衰老、抗辐射、抗应激、抗氧化等作用。
肉苁蓉提取物补肾阳，益精血，润肠通便。用于阳痿，不孕，腰膝酸软，筋骨无力，肠燥便秘。
黄精提取物对伤寒杆菌、金黄色葡萄球菌、抗酸杆菌有抑制作用，2％黄精在沙氏培养基内对常见致病真菌有不同程度的抑制作用。对肾上腺素引起的血糖过高呈显著抑制作用。抗疲劳作用抗氧化作用，延缓衰老，止血。抗病毒作用。
玉竹提取物主治养阴润燥，生津止渴。用于肺胃阴伤，燥热咳嗽，咽干口渴，内热消渴。
灵芝提取物增强人体免疫力，调节血糖，控制血压，辅助肿瘤放化疗，保肝护肝，促进睡眠等方面均具有显著疗效。
天麻提取物有镇静、安眠作用，主入肝经，长于平肝息风，可治疗血虚肝风内动的头痛、眩晕，亦可用于小儿惊风、癫痫、破伤风。祛风止痛。天麻有镇静、镇痛、抗惊厥作用；能增加脑血流量，降低脑血管阻力，轻度收缩脑血管，增加冠状血管流量；能降低血压，减慢心率，对心肌缺血有保护作用；天麻多糖有免疫活性。
锁阳提取物是补肾的药材中最常使用的一味药，它可平肝补肾、益精养血、润肠通便，治疗气血不足造成的不孕症，还可强筋健骨、补充钙质。对人体机能有很大益处；增强免疫功能；清除自由基；抗血小板聚集；具有糖类皮质激素样作用；补充维生素和矿物质。最新科学实验证明锁阳还具有防癌、抗病毒、延缓衰老的作用。适用于免疫力低下、易感染疾病者；中青年操劳事业而健康透支者；尿频便秘、失眠脱发、哮喘、痿弱早泄等多种慢性疾病患者。
淫羊藿提取物补肾阳，强筋骨，祛风湿。用于阳痿遗精，筋骨痿软，风湿痹痛，麻木拘挛；更年期高血压。
本发明采用以上组方，作用全面，有生血补气，滋阴补肾，壮阳，提神，促进睡眠，抗疲劳，抗衰老，防脱发，增强性功能，提高生育功力，预防高血压，糖尿病。有保持青春活力，延年益寿的作用。同时，本发明均采用提取物而非直接服用，有效营养成分含量高，更有利于吸收。
在上述方案中：将本方制成0.5g/粒的胶囊。头两个星期早晚各服4粒，以后早晚各服2粒。服用方便。感冒发烧停用。
在上述方案中：将本方制成1g/片的片剂。头两个星期早晚各吃1片，以后早晚各吃一片。服用方便。感冒发烧停用。
本发明的有益效果是：本发明为纯中药制剂，作用全面，有生血补气，滋阴补肾，壮阳，提神，促进睡眠，抗疲劳，抗衰老，防脱发，增强性功能，提高生育功力，预防高血压，糖尿病。有保持青春活力，延年益寿的作用。同时，本发明均采用提取物而非直接服用，有效营养成分含量高，更有利于吸收。适合现代男性使用。
具体实施方式
下面结合实施例对本发明做进一步的描述。
实施例1
一种男性日用保健品，由重量份数的以下组份组成：西洋参根部提取物0.3份，当归提取物0.5份、党参提取物0.5份，枸杞提取物1份、何首乌提取物1份，熟地提取物0.5份，菟丝子提取物0.3份，黄氏多糖0.3份，肉苁蓉提取物0.3份，黄精提取物0.5份，玉竹提取物1份，灵芝提取物0.5份，天麻提取物0.5份，锁阳提取物0.5份，淫羊藿提取物0.3份。制成0.5g/粒的胶囊。
实施例2
一种男性日用保健品，由重量份数的以下组份组成：西洋参根部提取物0.8份，当归提取物1.5份、党参提取物1.5份，枸杞提取物2份、何首乌提取物2份，熟地提取物1.5份，菟丝子提取物0.8份，黄氏多糖0.8份，肉苁蓉提取物0.8份，黄精提取物1.5份，玉竹提取物2份，灵芝提取物1.5份，天麻提取物1.5份，锁阳提取物1.5份，淫羊藿提取物0.8份。将本方制成1g/片的片剂。
实施例3
一种男性日用保健品，由重量份数的以下组份组成：西洋参根部提取物0.4份，当归提取物0.8份、党参提取物0.8份，枸杞提取物1.2份、何首乌提取物1.2份，熟地提取物0.8份，菟丝子提取物0.4份，黄氏多糖0.4份，肉苁蓉提取物0.4份，黄精提取物0.8份，玉竹提取物1.2份，灵芝提取物0.8份，天麻提取物0.8份，锁阳提取物0.8份，淫羊藿提取物0.4份。
实施例4
一种男性日用保健品，由重量份数的以下组份组成：西洋参根部提取物0.6份，当归提取物1.2份、党参提取物1.2份，枸杞提取物1.8份、何首乌提取物1.8份，熟地提取物1.2份，菟丝子提取物0.6份，黄氏多糖0.6份，肉苁蓉提取物0.6份，黄精提取物1.2份，玉竹提取物1.8份，灵芝提取物1.2份，天麻提取物1.2份，锁阳提取物1.2份，淫羊藿提取物0.6份。
本发明目前已经成功用于352例现代男性，年龄在25-35岁10％，35-39岁20％，40-45岁30％，45-50岁40％。均表现为易疲劳，脱发，性功能下降，按照本发明的方法服用本发明一年后，无脱发现象，性功能提高，不易出现疲劳，睡眠质量好，精神好。
本发明不局限于具体实施例，应当理解，本领域的普通技术人员无需创造性劳动就可以根据本发明的构思做出诸多修改和变化。总之，凡本技术领域中技术人员依本发明的构思在现有技术的基础上通过逻辑分析、推理或者有限的实验可以得到的技术方案，皆应在由权利要求书所确定的保护范围内。
Claims (4)
1.一种男性日用保健品，其特征在于：由重量份数的以下组份组成：西洋参根部提取物0.3-0.8份，当归提取物0.5-1.5份、党参提取物0.5-1.5份，枸杞提取物1-2份、何首乌提取物1-2份，熟地提取物0.5-1.5份，菟丝子提取物0.3-0.8份，黄氏多糖0.3-0.8份，肉苁蓉提取物0.3-0.8份，黄精提取物0.5-1.5份，玉竹提取物1-2份，灵芝提取物0.5-1.5份，天麻提取物0.5-1.5份，锁阳提取物0.5-1.5份，淫羊藿提取物0.3-0.8份。
2.根据权利要求1所述男性日用保健品，其特征在于：由重量份数的以下组份组成：西洋参根部提取物0.4-0.6份，当归提取物0.8-1.2份、党参提取物0.8-1.2份，枸杞提取物1.2-1.8份、何首乌提取物1.2-1.8份，熟地提取物0.8-1.2份，菟丝子提取物0.4-0.6份，黄氏多糖0.4-0.6份，肉苁蓉提取物0.4-0.6份，黄精提取物0.8-1.2份，玉竹提取物1.2-1.8份，灵芝提取物0.8-1.2份，天麻提取物0.8-1.2份，锁阳提取物0.8-1.2份，淫羊藿提取物0.4-0.6份。
3.根据权利要求1或2所述男性日用保健品，其特征在于：将本方制成0.5g/粒的胶囊。
4.根据权利要求1或2所述男性日用保健品，其特征在于：将本方制成1g/片的片剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410745593.4A CN104432046B (zh) | 2014-12-09 | 2014-12-09 | 男性日用保健品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410745593.4A CN104432046B (zh) | 2014-12-09 | 2014-12-09 | 男性日用保健品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN104432046A true CN104432046A (zh) | 2015-03-25 |
| CN104432046B CN104432046B (zh) | 2016-06-15 |
Family
ID=52879393
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410745593.4A Active CN104432046B (zh) | 2014-12-09 | 2014-12-09 | 男性日用保健品 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104432046B (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796942A (zh) * | 2016-03-10 | 2016-07-27 | 厦门塔斯曼生物工程有限公司 | 一种提高动物或人体体力的配方 |
| CN107692220A (zh) * | 2017-10-09 | 2018-02-16 | 湖南善仁堂药业有限公司 | 增强人体免疫力的保健药膳食品及制备方法 |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1131028A (zh) * | 1995-03-11 | 1996-09-18 | 高风兰 | 一种营养保健口服液 |
| KR20090101397A (ko) * | 2008-03-23 | 2009-09-28 | 장선택 | 한약재가 혼합된 나노공법에 의한 초미세 기능성 생식분말 |
| CN101669984A (zh) * | 2008-09-13 | 2010-03-17 | 王小根 | 抗疲劳免疫调节的中药制成品 |
| CN101972355A (zh) * | 2010-11-03 | 2011-02-16 | 马青林 | 一种综合补肾的中药 |
| CN102453657A (zh) * | 2010-10-19 | 2012-05-16 | 黄步新 | 一种黄芪药酒的制备方法 |
-
2014
- 2014-12-09 CN CN201410745593.4A patent/CN104432046B/zh active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1131028A (zh) * | 1995-03-11 | 1996-09-18 | 高风兰 | 一种营养保健口服液 |
| KR20090101397A (ko) * | 2008-03-23 | 2009-09-28 | 장선택 | 한약재가 혼합된 나노공법에 의한 초미세 기능성 생식분말 |
| CN101669984A (zh) * | 2008-09-13 | 2010-03-17 | 王小根 | 抗疲劳免疫调节的中药制成品 |
| CN102453657A (zh) * | 2010-10-19 | 2012-05-16 | 黄步新 | 一种黄芪药酒的制备方法 |
| CN101972355A (zh) * | 2010-11-03 | 2011-02-16 | 马青林 | 一种综合补肾的中药 |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105796942A (zh) * | 2016-03-10 | 2016-07-27 | 厦门塔斯曼生物工程有限公司 | 一种提高动物或人体体力的配方 |
| CN107692220A (zh) * | 2017-10-09 | 2018-02-16 | 湖南善仁堂药业有限公司 | 增强人体免疫力的保健药膳食品及制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| CN104432046B (zh) | 2016-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100335107C (zh) | 一种保健药酒 | |
| CN104862190A (zh) | 一种红枣枸杞保健酒 | |
| CN104388259A (zh) | 一种红豆杉果肉养生保健酒的制作方法 | |
| CN103555530A (zh) | 百合保健药酒 | |
| CN107853517B (zh) | 一种提神抗疲劳的中药饮料及其制备方法 | |
| CN104382036B (zh) | 女性日用保健品 | |
| CN104432046B (zh) | 男性日用保健品 | |
| CN102715509B (zh) | 一种排毒养颜保健品 | |
| CN102961611A (zh) | 一种保健药酒及其制备方法 | |
| CN102058775B (zh) | 一种保健降压茶及其制造方法 | |
| CN104208339A (zh) | 一种用于治疗畜禽细菌性、病毒性疾病的中药组合物及其制备方法 | |
| CN101249255B (zh) | 一种治疗小儿咳嗽的中成药及其制备方法 | |
| CN110495536A (zh) | 一种老年人多功能保健饮料配方及制备方法 | |
| CN107233488A (zh) | 一种延缓细胞及血管衰老的中药组合物 | |
| CN108159191B (zh) | 壮阳健肾的组合物、用途和口服液及其制备方法 | |
| CN112402569A (zh) | 一种抗疲劳保健品及其制备方法 | |
| CN114748583A (zh) | 一种滋补养生的中药药酒 | |
| CN105213905A (zh) | 一种防治绝经后骨质疏松症的中药组合物及其应用 | |
| CN104988017A (zh) | 保健果酒及其制备方法 | |
| CN110613810A (zh) | 一种用于调理亚健康的中药组合物及其制备方法 | |
| CN102613628A (zh) | 一种原生态椰锗汁及其生产方法 | |
| CN106106919A (zh) | 一种含有黄皮叶的保健茶饮料及其制备方法 | |
| CN107362170A (zh) | 一种治疗痛风的复合多糖及其制备方法 | |
| CN105194433A (zh) | 一种内科治疗老年体虚症的中药组合物 | |
| CN103977135A (zh) | 一种用于中老年补益肝肾的中药组合物及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20220223 Address after: 402160 Yongqing Road, Yongchuan District, Chongqing Patentee after: CHONGQING ZONGYI PHARMACEUTICAL Co.,Ltd. Address before: 402160 No. 67, South Street, Yongchuan District, Chongqing Patentee before: CHONGQING ZONGYI NUTRITION TECHNOLOGY Co.,Ltd. |
|
| TR01 | Transfer of patent right |